Positive effect of modified goeckerman regimen on quality of life and psychosocial distress in moderate and severe psoriasis

Acta Dermato-Venereologica

Volumn 91, Issue 4, 2011, Pages 447-451

  Chern, Erick ^a,b   Yau, Diana ^c   Ho, Ji Chen ^a,b   Wu, Wei Ming ^a,b   Wang, Cheng Yu ^a,b   Chang, Hsueh Wen ^c   Cheng, Yu Wen ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Cost effectiveness; Modified goeckerman; Psoriasis; Psychosocial stress; Quality of life

Indexed keywords

COAL TAR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG DOSE INCREASE; FEMALE; HOSPITAL ADMISSION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HOSPITAL DISCHARGE; HUMAN; MALE; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; RADIATION DOSE; SOCIAL STRESS; ULTRAVIOLET RADIATION;

ADULT; ANXIETY; CASE-CONTROL STUDIES; COAL TAR; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; DEPRESSION; DISABILITY EVALUATION; FEMALE; HEALTH CARE COSTS; HUMANS; KAPLAN-MEIER ESTIMATE; KERATOLYTIC AGENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; TAIWAN; TIME FACTORS; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 79958801856     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1096     Document Type: Article

References (14)

1. Chen HH, Tseng MP, Tsai TF. An epidemiologic study of Taiwanese psoriatic patients in a single clinic. Dermatol Sinica 2003; 21: 216-224.
2. Jobling R, Naldi L. Assessing the impact of psoriasis and the relevance of qualitative research. J Invest Dermatol 2006; 126: 1438-1440.
3. Lai CS, huang Ph, Ho JC. Treatment for psoriasis with modified goeckerman regimen - one year experience in Southern Taiwan. Dermatol Sinica 2005; 23: 113-120.
4. Gupta MA, Gupta AK. Psychodermatology: an update. J Am Acad Dermatol 1996; 34: 1030-1034.
5. Snaith RP. The hospital Anxiety and Depression scale. Health Qual Life outcomes 2003; 1: 29.
6. Zigmond AS, Snaith RP. The hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-370.
7. Leung CM, Ho S, Kan CS, Hung Ch, Chen CN. Evaluation of the Chinese version of the hospital Anxiety and Depression Scale. A cross-cultural perspective. Int J Psychosom 1993; 40: 29-34.
8. Lee E, Koo J. Modern modified"ultra" goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies. J Dermatolog Treat 2005; 16: 102-107.
9. Finlay AY, Khan GK, Luscombe DK, Salek MS. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 1990; 123: 751-756.
10. Gupta G, Long J, Tillman DM. The efficacy of narrowband ultraviolet B phototherapy in psoriasis using objective and subjective outcome measures. Br J Dermatol 1990; 140: 887-890.
11. Devrimci-ozguven H, Kundakci TN, Kumbasar H, Boyva A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 2000; 14: 267-271.
12. Sampogna F, Sera F, Abeni D. Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol 2004; 122: 602-607.
13. reimus JL, Vingerhoets AJ, Soons PH, Korstanje MJ. Suffering in psoriasis patients: its relation with illness severity and subjective well-being. Int J Dermatol 2007; 46: 1042-1045.
14. Fortune DG, Richards HL, Kirby B, Mcelhone K, Main CJ, Griffths CE. Successful treatment of psoriasis improves psoriasis-specifc but not more general aspects of patients' well-being. Br J Dermatol 2004; 151: 1219-1226.